Regional Scientific Director, Mid-Atlantic

Role: Regional Scientific Director (Associate Director level) focusing on establishing scientific partnerships within the healthcare community for Intellia's CRISPR-based gene editing programs, nex-z and lonvo-z, in the Mid-Atlantic region. Responsibilities include engaging KOLs and trial sites in ATTR amyloidosis and HAE, providing medical education on gene editing mechanisms and clinical data, supporting Phase 3 clinical trial activities, and assisting with site activation and patient recruitment. The role involves developing tailored engagement plans, identifying insights and knowledge gaps, attending medical congresses, and ensuring compliance in scientific interactions. Requirements: Doctorate (Pharm.D., Ph.D., M.D., D.O.), 3+ years in industry or related fields, extensive experience supporting Phase 3 clinical trials, and strong scientific communication skills. Preferred qualifications include therapeutic expertise in allergy/immunology/HAE, cardiology/ATTR-CM/-PN, or genetic medicine, along with experience in product launches. Key biopharma specifics: focus on gene editing therapies, clinical trial support, and engagement with healthcare professionals across the specified neurological and genetic conditions. The role demands 50-70% travel, remote work from a home-based office, and proficient use of digital communication tools.